Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/1210422.pdf
Reference146 articles.
1. Abi-Habib RJ, Urieto JO, Liu S, Leppla SH, Duesbery NS, Frankel AE . (2005). BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin. Mol Cancer Ther 4: 1303–1310.
2. Agus DB, Gordon MS, Taylor C, Natale RB, Karlan B, Mendelson DS et al. (2005). Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. J Clin Oncol 23: 2534–2543.
3. Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y et al. (2005). Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37: 1038–1040.
4. Arslan MA, Kutuk O, Basaga H . (2006). Protein kinases as drug targets in cancer. Curr Cancer Drug Targets 6: 623–634.
5. Awada A, Hendlisz A, Gil T, Bartholomeus S, Mano M, de Valeriola D et al. (2005). Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. Br J Cancer 92: 1855–1861.
Cited by 2327 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring molecular mechanisms of diazinon toxicity in HT22 hippocampal neurons through integrated miRNA and mRNA profiling;Computers in Biology and Medicine;2024-11
2. Development of hybrid polyvinylpyrrolidone/carboxymethyl cellulose/collagen incorporated oregano scaffolds via direct ink write printing for potential wound healing applications;International Journal of Biological Macromolecules;2024-10
3. Ginsenoside CK ameliorates tumor growth in lung cancer mice via inhibiting EGFR;Journal of Functional Foods;2024-10
4. Design, synthesis and biological evaluation of a novel PAK1 degrader for the treatment of triple negative breast cancer;Bioorganic & Medicinal Chemistry;2024-10
5. Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP kinase inhibition against BRAF-mutated melanoma;Molecular Therapy - Nucleic Acids;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3